These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31169696)

  • 21. Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion.
    Nam SJ; Kim BC; Chang HJ; Jeon HH; Kim J; Kim SY
    Gut Liver; 2022 Mar; 16(2):228-235. PubMed ID: 34552040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal surgery and lymph node metastasis of duodenal bulbar neuroendocrine neoplasms.
    Kamiya A; Yoshikawa T; Sakon R; Ishizu K; Wada T; Hayashi T; Otsuki S; Yamagata Y; Katai H
    Eur J Surg Oncol; 2022 Mar; 48(3):597-603. PubMed ID: 35031158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
    Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
    J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.
    Kachare SD; Liner KR; Vohra NA; Zervos EE; Fitzgerald TL
    Am Surg; 2014 Aug; 80(8):821-6. PubMed ID: 25105406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.
    Kang HS; Kwon MJ; Kim TH; Han J; Ju YS
    Pathol Res Pract; 2019 Nov; 215(11):152642. PubMed ID: 31585816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
    Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
    J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-functional duodenal neuroendocrine neoplasia in the proximal duodenum--case reports and proposal for a "high-risk-/low-risk-concept" in the decision for local endoscopic therapy].
    Scheerer F; Schmitt W
    Z Gastroenterol; 2013 Nov; 51(11):1240-50. PubMed ID: 24243571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
    Ugras N; Hasdemir S; Yerci Ö; Taşar P; Dündar HZ; Macunluoğlu AC
    Tumori; 2021 Feb; 107(1):80-85. PubMed ID: 32705937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
    Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
    Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).
    Rault-Petit B; Do Cao C; Guyétant S; Guimbaud R; Rohmer V; Julié C; Baudin E; Goichot B; Coriat R; Tabarin A; Ramos J; Goudet P; Hervieu V; Scoazec JY; Walter T
    Ann Surg; 2019 Jul; 270(1):165-171. PubMed ID: 29557879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric Neuroendocrine Tumors According to the 2019 World Health Organization Grading System: A Single-Center, Retrospective Study.
    Kim Y; Ahn B; Choi KD; Kim BS; Yook JH; Lee GH; Hong SM; Lee JH
    Gut Liver; 2023 Nov; 17(6):863-873. PubMed ID: 36588525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
    Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
    Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.
    Mekkan-Bouv Hez M; Derbey L; de Mestier L; Lorenzo D; Walter T; Perrier M; Cadiot G; Goichot B; Pracht M; Lièvre A; Coriat R; Valancot S; Guimbaud R; Carrere N; Bacoeur-Ouzillou O; Belleannée G; Smith D; Laboureau S; Hescot S; Julie C; Teissier MP; Thereaux J; Ferru A; Evrard C; Mathonnet M; Christou N
    Int J Surg; 2024 Jul; 110(7):4259-4265. PubMed ID: 38573078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program.
    Wang R; Mohapatra S; Jovani M; Akshintala VS; Kamal A; Brewer OG; Kumbhari V; Shin EJ; Canto MI; Khashab MA; Singh VK; Lennon AM; Kalloo AN; Ngamruengphong S
    Gastrointest Endosc; 2021 Jun; 93(6):1384-1392. PubMed ID: 33347833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study.
    Hirasawa T; Yamamoto N; Sano T
    Dig Endosc; 2021 Mar; 33(3):408-417. PubMed ID: 32578248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.